News & Publications

Video Gallery

CRI programs have been instrumental in pioneering the field and funding discoveries, offering hope for the ultimate prevention and treatment of cancer using our immune system.

Watch interviews with our scientists to learn more about their groundbreaking research and its impact on patients, roundtable discussions from experts at CRI conferences and meetings, as well as public service announcements highlighting CRI's role in the field of cancer immunotherapy.

Stories are the most powerful way of raising awareness about cancer immunotherapy and enlisting more people to join in the movement to end cancer through immune-based treatments. - See more at: http://cri-stage.ecentricarts.com/get-involved/share-your-story#sthash.DR0CPgRE.dpuf


Page 2 of 3
  • A Vaccine for Cancer

    A Vaccine for Cancer

    "A Vaccine for Cancer" is an informative nine-minute video about the Cancer Research Institute (CRI) and the exciting discoveries CRI is making in cancer vaccine research though its innovative international clinical research program, the Cancer Vaccine Collaborative (CVC).
  • Counting On It: New Hope from the Cancer Research Institute

    Counting On It: New Hope from the Cancer Research Institute

    In this public service announcement, MSNBC TV news anchor Alex Witt shares the message of new hope for cancer patients, thanks to the promising laboratory and clinical studies of Cancer Research Institute scientists who are learning how to harness the power of our own immune systems to fight cancer.
  • Redefining Cure: How Science Is Reshaping Our Perception of Cancer and How To Treat It

    Redefining Cure: How Science Is Reshaping Our Perception of Cancer and How To Treat It

    Many cancer charities today say they're working toward finding "the cure" for cancer. But what exactly does that mean? A treatment that eliminates cancer completely and permanently would be ideal. But is it realistic?
  • Cancer, Aging, and Immunity

    Cancer, Aging, and Immunity

    Matthew Youngman, Ph.D., is a CRI-funded postdoctoral fellow who is studying the effects of aging on the immune system.
  • Conquering Blood Cancer: Finding New Therapeutic Targets for Multiple Myeloma

    Conquering Blood Cancer: Finding New Therapeutic Targets for Multiple Myeloma

    Cancer Research Institute postdoctoral fellow Diego Acosta-Alvear, Ph.D., in the laboratory of Peter Walter, Ph.D., at the University of California, San Francisco - Howard Hughes Medical Institute in San Francisco, CA, is helping to conquer blood cancers by studying the regulation of the unfolded protein response in multiple myeloma.
  • Cancer Vaccine Showing Promise in Ovarian Cancer Trials

    Cancer Vaccine Showing Promise in Ovarian Cancer Trials

    CRI investigator Dr. Kunle Odunsi,discusses how his ovarian cancer vaccine helped to boost the immune response against cancers that carry the NY-ESO-1 protein marker in ovarian cancer survivor Christine Sable.
  • 2012 CIC Roundtable: Benefit/Risk of Immunotherapy

    2012 CIC Roundtable: Benefit/Risk of Immunotherapy

    Panel discussion of the benefits and risks of immunotherapy at the 2012 CRI Cancer Immunotherapy Consortium Annual Colloquium.
  • 2012 William B. Coley Award in Tumor Immunology to Dr. Carl June

    2012 William B. Coley Award in Tumor Immunology to Dr. Carl June

    Drs. Carl H. June and Michel Sadelain jointly accept the 2012 William B. Coley Award for Distinguished Research in Tumor Immunology for their outstanding contributions to the development of adoptive T cell transfer therapy for cancer patients, in particular chimeric antigen receptor T cells engineered to target and attack cancer.
  • 2012 Oliver R. Grace Award

    2012 Oliver R. Grace Award

    Mark P. Frissora, chairman and CEO of Hertz Corporation,and Dr. Severin Schwan, CEO of Roche receive the 2012 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
  • 2012 William B. Coley Award for Distinguished Research in Basic Immunology

    2012 William B. Coley Award for Distinguished Research in Basic Immunology

    Drs. Richard A. Flavell, Laurie H. Glimcher, and Kenneth M. Murphy jointly receive the 2012 William B. Coley Award for Distinguished Research in Basic Immunology.

Meet Other CRI Patients

When Sharon Belvin learned that she had advanced melanoma at 22 years old, she enrolled in a CRI-funded clinical trial for a new antibody therapy called anti-CTLA-4. Today, the mother of two is still cancer free. Read more about her story and other cancer survivors who used these powerful new treatments called immunotherapies.

Stay Informed

Stay up-to-date with the latest cancer immunotherapy news from CRI by signing up for our e-newsletter or alerts.

Subscribe

Share Your Story